Health News
Boston Globe
PhysOrg.com
Controlling blood pressure from middle-age onwards may cut the chances of developing dementia, say researchers.
Blow for GSK's breast cancer drug Financial Times, UK - 2 hours ago By Andrew Jack The British government's medicines advisory body has advised against the use of GlaxoSmithKline's oral cancer drug Tyverb in the National ...
A US doctor sparks controversy by saying couples having IVF are being "misled" about the risks of twin pregnancies.
Why should victims of mesothelioma or their families call the Mesothelioma Victims Center First? According to Americas Watchdog, "its pretty simple, we will tell them the truth about treatment options, will make sure the victims or their families find the right lawyers, we will help with Social Security or VA benefits, and everything else they need to know, and our service is free". The Mesothelioma Victims Center was created to assist all US victims of Mesothelioma. Americas Watchdog has initiated this very complete free service because there is literally nothing close to this type of service in the United States, and because this type of service is sorely needed by Mesothelioma victims and their families.
Inovio Biomedical Corporation (AMEX:INO), a developer of electroporation-based DNA vaccine delivery technology, and VGX Pharmaceuticals, Inc., a privately held DNA vaccine developer, announced today the signing of a definitive merger agreement, which provides for the issuance of Inovio Biomedical securities in exchange for all of the outstanding securities of VGX Pharmaceuticals. Each company’s board of directors has approved the merger agreement and the all-stock transaction it contemplates. The transaction is subject to completion of the registration of the Inovio Biomedical securities to be issued with the U.S.
PolyMVAHealthClub.com announces the immediate availability of Poly-MVA for Pets, a dietary supplement that has been shown to be very effective in human clinical cancer studies (studies conducted by a renowned board-certified oncologist, Dr. James Forsythe). (PRWeb Jul 7, 2008) Read the full story at http://www.prweb.com/releases/animal/health/prweb1074814.htm
Pop culture, anti-tobacco awareness and physical endurance merged last Friday in The TRUTH's 'Miley Mania Adventure' in Salt Lake City. Utah's smoking rates are the lowest in the nation, thirty-eight percent fewer high school students smoke today than they did in the early days of the state-wide The TRUTH campaign in 1999. The campaign's youth-focused efforts continue to help drive smoking rates down in Utah thanks, in part, to events like last week's "Miley Mania Adventure" in Salt Lake City. (PRWeb Jul 7, 2008) Read the full story at
Treating pediatric obstructive sleep apnea (OSA) with either orthodontic expansion or adenotonsillectomy improves symptoms, but most young children need both treatments to have complete resolution of OSA symptoms, according to a study in the July 1 issue of the journal Sleep.
A study in the July 1 issue of the journal Sleep shows that episodes of sleep-disordered breathing accompanied by mild oxygen desaturations of as little as two percent are associated with hyperglycemia. Adults with 11 or more apnea-hypopnea events per hour with an oxygen desaturation of 2.0 percent to 2.9 percent had an adjusted cumulative odds ratio of 1.41 for impaired fasting glucose or diabetes.
A study in the July 1 issue of the journal Sleep provides visual evidence of the severe structural damage that occurs in numerous regions of the brain in people with obstructive sleep apnea (OSA). Results show that OSA patients have extensive alterations in "white matter," nerve tissue in the brain containing fibers that are insulated with myelin - a white, fatty sheath.
Two studies in the July 1 issue of the journal Sleep analyze menopausal sleep problems, finding that complaints may differ according to the stage of menopausal transition and the ethnicity of the woman, and identifying risk factors that may predict sleep problems at any stage of menopause. A multi-ethnic study of more than 3,000 women shows that the odds of having trouble falling asleep and staying asleep increase through the menopausal transition.
Two studies in the July 1 issue of the journal Sleep analyze menopausal sleep problems, finding that complaints may differ according to the stage of menopausal transition and the ethnicity of the woman, and identifying risk factors that may predict sleep problems at any stage of menopause. A multi-ethnic study of more than 3,000 women shows that the odds of having trouble falling asleep and staying asleep increase through the menopausal transition.
With today's hectic lifestyle, where most women are juggling careers, family, relationships, and a host of activities, the idea of possibly facing a serious illness in the future is not something that readily comes to mind -- especially when a woman is in the prime of her life.
Vaginal microbicides currently in clinical trials may be the only weapon that will protect women against infection from HIV. Yet, under likely circumstances, these microbicides may be of more benefit to men than women, according to a new UCLA AIDS Institute study. The study, which used novel mathematical models to simulate clinical trials and population-level transmission of HIV, appears July 7 in the online issue of Proceedings of the National Academy of Sciences.
A cross-party group of MPs will attempt next week to end the need for a second doctor to give their approval for an abortion.
Guidelines for the treatment of older patients with respiratory conditions are routinely ignored. Research published in the open access journal BMC Health Services Research shows that recommended treatments are given to only a small minority of eligible patients. Benjamin Craig from the Moffitt Cancer Center, Tampa, USA, led a team who investigated the treatment of nearly 30,000 patients across the US.
Panic, staffing issues and geographic boundaries are some of the challenges that public health experts need to address as they plan for a possible influenza pandemic, according to a new report from Purdue University.
After 30 years of IVF, the rewards of treatment are still largely confined to industrialised countries and those who can afford it. Now, a Special Task Force of ESHRE has set about the immeasurable task of making fertility treatment more accessible to developing countries through a programme of pilot projects, professional awareness and involvement of government and non-governmental agencies. The Task Force faces a huge challenge.